Recursion Pharmaceuticals
Entry
2020
Hold
1yr
Exit
2021
Who owns Recursion Pharmaceuticals?
Recursion Pharmaceuticals is an American Biotech company, formerly owned by Leaps by Bayer, exited in 2021 (exit via IPO). No current private equity owner is on file.
Hand-verified · updated 2026-07-03
Open JSON · CC-BYExit Type
IPO
Exit Year
2021
More from Leaps by Bayer
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Recursion Pharmaceuticals?
Recursion Pharmaceuticals was formerly owned by Leaps by Bayer, exited in 2021. No current private equity owner is on file.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue